Roberto Di Santo

Title: The Innovative Contributions of Roberto Di Santo

Introduction

Roberto Di Santo is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with serotoninergic activity and inhibitors for retroviral integrase. With a total of 2 patents, his work has the potential to impact the treatment of various health conditions.

Latest Patents

Di Santo's latest patents include a compound with serotoninergic activity, which involves a process for preparing it and a pharmaceutical composition comprising it. This compound is defined by a specific formula, where R1, R2, and R3 are detailed in the accompanying description. The invention also encompasses a process and an intermediate for preparing the compound, as well as its use in treating disturbances of the serotoninergic system. Another significant patent involves quinolin-4-ones as inhibitors of retroviral integrase, specifically targeting HIV-1 integrase. These novel quinoline inhibitors can be utilized for preventing or treating AIDS or HIV infection in affected individuals.

Career Highlights

Throughout his career, Roberto Di Santo has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Di Santo has collaborated with notable colleagues, including Roberta Costi and Yves Pommier. These partnerships have likely enhanced his research efforts and broadened the scope of his inventions.

Conclusion

Roberto Di Santo's innovative work in the pharmaceutical field demonstrates his commitment to advancing medical science. His patents reflect a deep understanding of complex biochemical processes and a dedication to improving health outcomes.